Together, these results indicate that in the background of Vangl2Lp/+, the occurrence of spina bifida due to the heterozygosity of Cdh2 was not evoked by changes in the signal strength of the RhoA-Mypt1 or JNK-Jun pathways. The gene discussed is CDH2; the disease is spina bifida.